Cell Therapeutics withdraws pixantrone from FDA consideration

Seattle-based Cell Therapeutics (CTI) has withdrawn its application for approval of pixurvi (pixantrone) from the U.S. Food & Drug Administration due to what the company is calling 'unresolved communications' with the regulatory agency.

The FDA's oncology advisory committee was planning on reviewing pixantrone next week and issuing its recommendation to the FDA, which had planned to announce by April 24 whether or not the third-line therapy for relapsed or refractory non-Hodgkin's lymphoma would be approved.

CTI's decision to withdraw the drug from consideration may indicate that the committee was leaning toward rejection, which would have been in line with how the committee and agency have felt about pixantrone since the company submitted its disastrous phase III data last year.

CTI says it will resubmit the drug in the near future. Either way, with this withdrawal CTI remains a bizarre biopharmaceutical company, one that has managed to be in business for two decades without ever having developed a drug for approval or, arguably, made much money at all, although they have spent money in the hundreds of millions. In fact, unlike the company's many shareholders, CTI's CEO, James Bianco, was awarded handsomely last year, along with other company principles.

Source: The Street

More Articles

More Articles

This entry looks at what is sometimes referred to as mesenteric lymphoma, also referred to as non-Hodgkin's...

In T cell lymphoma, T lymphocytes, which are an essential part of the body's immune response, become malignant. T cell lymphomas account for about...

Lymphoma is a cancer affecting the white blood cells (lymphocytes) of the body's immune system. The cells begin to grow abnormally and much faster...

RICE is an acronym for an anti-cancer treatment that expresses a combination chemotherapeutic regimen. This regimen is written variously as "R+ICE...

B cell lymphoma is not one disease but a few dozen heterogeneous diseases, or individual cancers, that affect the b...

Mantle cell lymphoma (MCL) is just one of 50-60 known B-cell subtypes of...

What causes lymphoma is not well known. DNA mutations may be what causes lymphoma to develop but what triggers these mutations is...

A B cell is a type of lymphocyte that produces antibodies to fight infections. These are the most prevalent lymphocytes in the bloodstream and are...

Also known as Hodgkin's disease, Hodgkin's lymphoma (HL) is a cancer of the white blood cells, or...

Canine lymphoma, just like lymphoma in humans, can be separated into stages,...

This article looks at the Non-Hodgkin's Lymphoma survival rate as well as the Non-Hodgkin's Lymphoma mortality rate ....

T-Cell Lymphoblastic Lymphoma (T-LBL) is a very rare subtype of non-Hodgkin's lymphoma. It tends to develop in...

It's not uncommon for patients with some lymphomas to experience itching (clinically known as pruritus). Lymphoma itching symptoms can range from...

In non-Hodgkin's lymphoma, you have your B-cell lymphomas and you have your T-cell lymphomas.

Why B...